NanoImaging Services Secures $7.5M Funding to Drive Cryo-EM Advancements for Drug Development

In a significant boost to its ongoing mission to transform drug development, NanoImaging Services (NIS) has successfully raised $7.5 million in funding. With a legacy as the industry leader in cryo-electron microscopy (cryo-EM), NIS stands at the forefront of visualizing biomolecular structures, providing critical insights that enhance various stages of the drug discovery pipeline—from target identification to formulation and manufacturing. This latest influx of capital will enable NIS to expand its capabilities in structural biology and nanoparticle characterization, directly impacting its offering of high-resolution data collection and single-particle analysis which can yield structural models in an impressive average of just four weeks. With the largest team of cryo-EM scientists and an unmatched inventory of transmission electron microscopes in North America, NIS is uniquely equipped to provide comprehensive morphology assessments. The funding will also facilitate the growth of NIS's R&D and GMP-compliant services, ensuring that drug developers—regardless of their size—have access to top-tier cryo-EM technology to accelerate the development of life-changing therapeutics. As NIS continues to push the boundaries of what’s possible in biostructural analysis, this new financial backing stands to significantly enhance its infrastructure, research capabilities, and service offerings, ultimately contributing to a more efficient and innovative drug development landscape.